NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
Epithelial to mesenchymal transition (EMT) plays an important role in many biological processes. The latest studies revealed that aggressive breast cancer, especially the triple-negative breast cancer (TNBC) subtype was frequently associated with apparent EMT, but the mechanisms are still unclear. N...
Main Authors: | Chenfei Kong, Changqing Wang, Liping Wang, Musong Ma, Chunbo Niu, Xiaoqian Sun, Juan Du, Zhixiong Dong, Shan Zhu, Jun Lu, Baiqu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3145662?pdf=render |
Similar Items
-
Genome-wide analysis of histone H3 lysine9 modifications in human mesenchymal stem cell osteogenic differentiation.
by: Jiang Tan, et al.
Published: (2009-01-01) -
Nedd9 regulates metastasis of non-small cell lung cancer through activation of epithelial-mesenchymal transition and tumor cells migration
by: Y.A. Topchu, et al.
Published: (2020-03-01) -
miR-107 is involved in the regulation of NEDD9-mediated invasion and metastasis in breast cancer
by: Jiamin Zhou, et al.
Published: (2022-05-01) -
Expression of NEDD9 in Transbronchial Biopsies of Lung Adenocarcinoma
by: Jelena Ostojić, et al.
Published: (2018-01-01) -
NEDD9 sustains hexokinase expression to promote glycolysis
by: Alexander Y. Deneka, et al.
Published: (2022-04-01)